ROBO2 has been identified as a candidate tumor suppressor (Trifonov et al., 2013), and the alteration of its expression might play a role in malignant tumors of digestive tract including gastric and colorectal cancers (Je et al., 2013). Here, ROBO2 is linked to neoplasm.